www.fdanews.com/articles/113601-galapagos-partners-with-merck-shares-jump
Galapagos Partners With Merck, Shares Jump
January 9, 2009
Shares in biotech company Galapagos rose after it signed a multi-year deal with Merck & Co to develop new obesity and diabetes treatments, with an upfront payment of 1.5 million euros.
TradingMarkets
TradingMarkets